Eleven P15
Eleven P15
Eleven P15 creates Next Generation Diagnostics and Treatment for Pulmonary Fibrosis. The company focuses on the development of biomarkers that enable early detection of idiopathic pulmonary fibrosis and the discovery of genetically-targeted therapeutic approaches, enabling physicians to treat and prevent this incurable disease.
Company details
Find locations served, office locations.
- Business Type:
- Manufacturer
- Industry Type:
- Medical Research
- Market Focus:
- Nationally (across the country)